NeoPhore appoints Michael Shih as Chief Executive Officer
Published on 08/07/2025 at 18:06 | prnewswire.co.uk
Highly experienced corporate development leader with a track record of international pharma and biotech deal-makingNew CEO to drive growth strategy to maximise the potential of drug discovery pipeline to treat cancerView original content:https://www.prnewswire.co.uk/news-releases/neophore-appoints-michael-shih-as-chief-executive-officer-302331550.html
en | boerse | 67952337 |
